Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| index_oncology [2024/11/05 01:49] – removed - external edit (Unknown date) 127.0.0.1 | index_oncology [2024/11/05 01:49] (current) – ↷ Page name changed from oncology to index_oncology jkohts | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Drugs in oncology ====== | ||
| + | |||
| + | |||
| + | <WRAP column 30%> | ||
| + | * Alkylating agents | ||
| + | * Cyclophosphamide | ||
| + | * Platinum analogs | ||
| + | * Cisplatin | ||
| + | * Carboplatin | ||
| + | * Oxaliplatin | ||
| + | * Antimetabolites | ||
| + | * 5-fluorouracil | ||
| + | * Methotrexate | ||
| + | * Natural products | ||
| + | * Taxanes | ||
| + | * Paclitaxel | ||
| + | * Docetaxel | ||
| + | * Topoisomerase inhibitors | ||
| + | * Etoposide | ||
| + | * Anti-tumor antibiotics | ||
| + | * Bleomycin | ||
| + | * Daunorubicin | ||
| + | * Doxorubicin | ||
| + | * Dactinomycin | ||
| + | * Vinca alkaloids | ||
| + | * Vinblastine | ||
| + | * Vincristine | ||
| + | </ | ||
| + | |||
| + | |||
| + | <WRAP column 30%> | ||
| + | * Targeted cancer therapies | ||
| + | * PARP inhibitors | ||
| + | * Tyrosine kinase inhibitors | ||
| + | * BCR-ABL | ||
| + | * Imatinib | ||
| + | * HER2 | ||
| + | * Trastuzumab | ||
| + | * Anti-VEGF | ||
| + | * Sunitinib | ||
| + | * mTOR pathway | ||
| + | * SERM - antiestrogen | ||
| + | * Tamoxifen | ||
| + | </ | ||
| + | |||
| + | |||
| + | <WRAP column 30%> | ||
| + | * Cancer immnunotherapy | ||
| + | * Immune checkpoint inhibitors | ||
| + | * CAR-T | ||
| + | * BiTE | ||
| + | </ | ||